{"transactions":[{"id":674892,"issuer":{"id":8396,"kind":"organization","name":"Vivos Therapeutics, Inc."},"owners":[{"id":19450,"kind":"person","name":"Amman Bradford K.","position":1,"cik":"0001425339","reported_name":"Amman Bradford K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-26T20:10:16.000Z","date":"2026-07-31","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0.41,"value":61500.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 31, 2026 (the \"Grant Date\"), the Reporting Person received a grant of 150,000 stock options, which grant was made under the Issuer's 2024 Omnibus Equity Incentive Plan. Stock options shall vest and become exercisable at the rate of 25,000 shares per month from November 1, 2026 through April 1, 2026."}],"balance_after":326533,"derivative":{"exercise_price":0.41,"expiration_date":"2036-07-31","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001493152-26-040238","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425339/000149315226040238/ownership.xml","form_type":"4"}},{"id":674891,"issuer":{"id":8396,"kind":"organization","name":"Vivos Therapeutics, Inc."},"owners":[{"id":19450,"kind":"person","name":"Amman Bradford K.","position":1,"cik":"0001425339","reported_name":"Amman Bradford K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2026-08-26T20:10:16.000Z","date":"2026-07-31","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0.41,"value":102500.0,"ownership":{"direct":true},"balance_after":250080,"source":{"system":"sec-edgar","filing":"0001493152-26-040238","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425339/000149315226040238/ownership.xml","form_type":"4"}},{"id":1349235,"issuer":{"id":8396,"kind":"organization","name":"Vivos Therapeutics, Inc."},"owners":[{"id":19450,"kind":"person","name":"Amman Bradford K.","position":1,"cik":"0001425339","reported_name":"Amman Bradford K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-27T21:43:54.000Z","date":"2024-11-26","kind":"grant","planned":false,"acquired":true,"shares":149533,"price":2.64,"value":394767.12,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On September 7, 2024 (the \"Grant Date\"), the Reporting Person received a grant of 180,533 stock options, which grant was made under but subject to stockholder approval of the Issuer's 2024 Omnibus Equity Incentive Plan and such grant at the Issuer's 2024 Annual Meeting. Such meeting was held, and such stockholder approval was obtained, on November 26, 2024. Stock options shall vest and become exercisable in three installments subject to achievement of the following three performance metrics: (1) quarter over quarter revenue growth of at least 15% over the same prior year quarter, (2) total stockholder return from date of grant, and (3) positive cash flow for two consecutive quarters."}],"balance_after":180533,"derivative":{"exercise_price":2.64,"expiration_date":"2034-09-07","underlying":"Common Stock","underlying_shares":149533},"source":{"system":"sec-edgar","filing":"0001493152-24-048023","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425339/000149315224048023/ownership.xml","form_type":"4"}},{"id":1467135,"issuer":{"id":8396,"kind":"organization","name":"Vivos Therapeutics, Inc."},"owners":[{"id":19450,"kind":"person","name":"Amman Bradford K.","position":1,"cik":"0001425339","reported_name":"Amman Bradford K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-29T00:53:46.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":2.38,"value":35700.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 20, 2024 (the \"Grant Date\"), the Reporting Person received a grant of 15,000 stock options from the Issuer. One-fifth vested immediately and one-fifth will vest annually on each anniversary of the Grant Date through June 20, 2028."}],"balance_after":31667,"derivative":{"exercise_price":2.38,"expiration_date":"2029-06-20","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001493152-24-025686","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425339/000149315224025686/ownership.xml","form_type":"4"}},{"id":2075479,"issuer":{"id":8396,"kind":"organization","name":"Vivos Therapeutics, Inc."},"owners":[{"id":19450,"kind":"person","name":"Amman Bradford K.","position":1,"cik":"0001425339","reported_name":"Amman Bradford K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-29T02:45:24.000Z","date":"2022-12-23","kind":"grant","acquired":true,"shares":200000,"price":0.48,"value":96000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"200,000 stock options granted on December 23, 2022. One-fifth vests annually on each anniversary date through December 23, 2026."}],"balance_after":500001,"derivative":{"exercise_price":0.48,"expiration_date":"2027-12-23","underlying":"Common Stock","underlying_shares":500001},"source":{"system":"sec-edgar","filing":"0001493152-22-036726","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425339/000149315222036726/ownership.xml","form_type":"4"}},{"id":2368777,"issuer":{"id":8396,"kind":"organization","name":"Vivos Therapeutics, Inc."},"owners":[{"id":19450,"kind":"person","name":"Amman Bradford K.","position":1,"cik":"0001425339","reported_name":"Amman Bradford K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-28T23:50:54.000Z","date":"2022-02-25","kind":"grant","acquired":true,"shares":50000,"price":3.27,"value":163500.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"50,000 stock options granted on February 25, 2022. One-fifth vested immediately and one-fifth vests annually on each anniversary date through February 25, 2026."}],"balance_after":50000,"derivative":{"exercise_price":3.27,"expiration_date":"2027-02-25","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-22-005660","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425339/000149315222005660/ownership.xml","form_type":"4"}},{"id":2581466,"issuer":{"id":8396,"kind":"organization","name":"Vivos Therapeutics, Inc."},"owners":[{"id":19450,"kind":"person","name":"Amman Bradford K.","position":1,"cik":"0001425339","reported_name":"Amman Bradford K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-03T01:27:19.000Z","date":"2018-10-22","kind":"grant","acquired":true,"shares":83334,"price":7.5,"value":625005.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"83,334 stock options granted on October 22, 2018. One-fifth vested immediately and one-fifth vests annually on each anniversary date through October 22, 2022"}],"balance_after":83334,"derivative":{"exercise_price":7.5,"expiration_date":"2023-10-22","underlying":"Common Stock","underlying_shares":83334},"source":{"system":"sec-edgar","filing":"0001493152-21-021915","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1425339/000149315221021915/ownership.xml","form_type":"4"}},{"id":2581465,"issuer":{"id":8396,"kind":"organization","name":"Vivos Therapeutics, Inc."},"owners":[{"id":19450,"kind":"person","name":"Amman Bradford K.","position":1,"cik":"0001425339","reported_name":"Amman Bradford K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-03T01:27:19.000Z","date":"2019-11-18","kind":"grant","acquired":true,"shares":16667,"price":7.5,"value":125002.5,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"16,667 stock options granted on November 18, 2019. One-fifth vested immediately and one-fifth vests annually on each anniversary date through November 18, 2023."}],"balance_after":16667,"derivative":{"exercise_price":7.5,"expiration_date":"2024-11-18","underlying":"Common Stock","underlying_shares":16667},"source":{"system":"sec-edgar","filing":"0001493152-21-021915","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1425339/000149315221021915/ownership.xml","form_type":"4"}},{"id":2581464,"issuer":{"id":8396,"kind":"organization","name":"Vivos Therapeutics, Inc."},"owners":[{"id":19450,"kind":"person","name":"Amman Bradford K.","position":1,"cik":"0001425339","reported_name":"Amman Bradford K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-03T01:27:19.000Z","date":"2021-03-12","kind":"grant","acquired":true,"shares":100000,"price":7.5,"value":750000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100,000 stock options granted on March 12, 2021. One-fifth vested immediately and one-fifth vests annually on each anniversary date through March 12, 2025."}],"balance_after":100000,"derivative":{"exercise_price":7.5,"expiration_date":"2026-03-12","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-21-021915","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1425339/000149315221021915/ownership.xml","form_type":"4"}},{"id":2581463,"issuer":{"id":8396,"kind":"organization","name":"Vivos Therapeutics, Inc."},"owners":[{"id":19450,"kind":"person","name":"Amman Bradford K.","position":1,"cik":"0001425339","reported_name":"Amman Bradford K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-03T01:27:19.000Z","date":"2021-08-31","kind":"grant","acquired":true,"shares":50000,"price":5.26,"value":263000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"50,000 stock options granted on August 31, 2021. One-fifth vested immediately and one-fifth vests annually on each anniversary date through August 31, 2025."}],"balance_after":50000,"derivative":{"exercise_price":5.26,"expiration_date":"2026-08-31","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-21-021915","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425339/000149315221021915/ownership.xml","form_type":"4"}},{"id":2696833,"issuer":{"id":8396,"kind":"organization","name":"Vivos Therapeutics, Inc."},"owners":[{"id":19450,"kind":"person","name":"Amman Bradford K.","position":1,"cik":"0001425339","reported_name":"Amman Bradford K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-05-26T01:45:31.000Z","date":"2021-05-25","kind":"purchase","acquired":true,"shares":1000,"price":5.29,"value":5290.0,"ownership":{"direct":true},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001493152-21-012902","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425339/000149315221012902/ownership.xml","form_type":"4"}},{"id":2781899,"issuer":{"id":8396,"kind":"organization","name":"Vivos Therapeutics, Inc."},"owners":[{"id":19450,"kind":"person","name":"Amman Bradford K.","position":1,"cik":"0001425339","reported_name":"Amman Bradford K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2021-03-18T00:48:47.000Z","date":"2021-03-12","kind":"grant","acquired":true,"shares":100000,"price":7.5,"value":750000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100,000 stock options granted on March 12, 2021. One-fifth vested immediately and one-fifth vests annually on each anniversary date through March 12, 2025."}],"balance_after":200001,"derivative":{"exercise_price":7.5,"expiration_date":"2026-03-12","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-21-006291","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425339/000149315221006291/ownership.xml","form_type":"4"}},{"id":2931193,"issuer":{"id":8396,"kind":"organization","name":"Vivos Therapeutics, Inc."},"owners":[{"id":19450,"kind":"person","name":"Amman Bradford K.","position":1,"cik":"0001425339","reported_name":"Amman Bradford K.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-12-28T11:21:08.000Z","date":"2020-12-24","kind":"purchase","acquired":true,"shares":1000,"price":7.38,"value":7380.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001493152-20-024301","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425339/000149315220024301/ownership.xml","form_type":"4"}}]}